Brief: BioArctic Says Sales Of Leqembi Reached EUR 200 Million In Eisai FY 2024
18/02/2025 07:16
Feb 18 (Reuters) - BioArctic AB BIOAb.ST :
* LEQEMBI® SALES REACHES €200 MILLION - FIRST SALES
MILESTONE
ACHIEVED
* BIOARCTIC AB - MILESTONE WAS REACHED AS SALES OF LEQEMBI
REACHED
EUR 200 MILLION IN EISAI FISCAL YEAR 2024
Source text: ID:nPn3RRJHVa
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln